You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 635 A novel site-directed chemical conjugation technology confers antitumor activity via native Fc receptor to plasma immunoglobulin by attaching tumor binders

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Immuno-conjugates and chimeric molecules
635 A novel site-directed chemical conjugation technology confers antitumor activity via native Fc receptor to plasma immunoglobulin by attaching tumor binders

 

Online download statistics by month:

Online download statistics by month: November 2020 to August 2024

AbstractFullPdf
Nov 2020116019
Dec 202022080
Jan 20211601
Feb 20211603
Mar 202140010
Apr 20212605
May 2021208
Jun 2021004
Jul 2021003
Aug 2021008
Sep 2021004
Oct 20216020
Nov 202120013
Dec 2021804
Jan 2022401
Feb 2022601
Mar 20221001
Apr 20222003
May 202220011
Jun 20221202
Jul 20221401
Aug 20224208
Sep 20221605
Oct 20221603
Nov 20221202
Dec 20222006
Jan 20233005
Feb 20231400
Mar 20231603
Apr 20231209
May 2023400
Jun 2023802
Jul 20231806
Aug 2023802
Sep 2023603
Oct 20231403
Nov 20232603
Dec 20232001
Jan 20241205
Feb 20242202
Mar 202444020
Apr 20241806
May 20241803
Jun 202464011
Jul 20245202
Aug 20241403
Total8840315